A Study of Gastroparesis Therapy Effectiveness


About this study

The purpose of this study is to use standardized and measurable ways to understand how gastroparesis therapy affects patient symptoms

Participation eligibility

Participant eligibility includes age, gender, type and stage of disease, and previous treatments or health concerns. Guidelines differ from study to study, and identify who can or cannot participate. There is no guarantee that every individual who qualifies and wants to participate in a trial will be enrolled. Contact the study team to discuss study eligibility and potential participation.

Inclusion Criteria

  • 18 years of age or older
  • Fluent in English
  • Diagnosed with gastroparesis at Mayo
  • Sign an informed consent form prior to registry initiation

Exclusion Criteria

  • Under 18 years of age
  • Non-fluent in English
  • Institutionalized or incarcerated
  • Has a legal guardian
  • Circumstances that may affect participation with the registry:
    • Inability to complete questionnaires
    • Other conditions or circumstances that in the investigator’s opinion would limit the patient’s ability to participate or complete the registry.


Participating Mayo Clinic locations

Study statuses change often. Please contact the study team for the most up-to-date information regarding possible participation.

Mayo Clinic Location Status

Rochester, Minn.

Mayo Clinic principal investigator

Yuri Saito Loftus, M.D.

Closed for enrollment

More information


Publications are currently not available

Mayo Clinic Footer